RESULT_COUNT: 214,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-10-17 12:07:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120716317.html?.tsrc=rss,Nevro Corp NYSE:NVRO
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : October 13, 2017",2017-10-13 15:06:33 +0000,http://finance.yahoo.com/r/07eec29a-ebc8-3bdd-a29c-9afd718a8f98/etfs-with-exposure-to-nevro-corp-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-10-10 12:02:48 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120248124.html?.tsrc=rss,Nevro Corp NYSE:NVRO
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : October 2, 2017",2017-10-02 14:59:41 +0000,http://finance.yahoo.com/r/8f05b9e5-43d2-3f43-a4be-c3c754f4d1ad/etfs-with-exposure-to-nevro-corp-october-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-10-02 12:01:43 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120143539.html?.tsrc=rss,Nevro Corp NYSE:NVRO
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. :NVRO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017",2017-09-29 13:04:56 +0000,http://finance.yahoo.com/r/df60988a-23ef-3bbe-832d-06609bab1d5b/nevro-corp-nvro-us-earnings-analysis-q2-2017-by-the-numbers-september-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Nevro Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 78.02 million, Net Earnings of USD -11.61 million. Gross margins widened from 65.29% to 68.26% compared to the same period last year, operating (EBITDA) margins now -11.94% from -9.99%. Change in operating cash ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-09-29 12:03:54 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120354383.html?.tsrc=rss,Short interest is moderate for NVRO with between 5 and 10% of shares outstanding currently on loan.  The net inflows of $1.89 billion over the last one-month into ETFs that hold NVRO are not among the highest of the last year and have been slowing.
NVRO,NVRO:US,BBG001K61W36,Nevro Trying To Close In On Key Technical Benchmark,2017-09-28 14:46:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-mAP8gUNAqE/nevro-trying-to-close-in-on-key-technical-benchmark-cm852557,On Thursday Nevro NVRO received a positive adjustment to its Relative Strength RS Rating from 65 to 72 ibd display video id 2102289 width 50 float left autostart true IBD s proprietary rating tracks market leadership with a 1 worst to 99 best score
NVRO,NVRO:US,BBG001K61W36,Nevro Trying To Close In On Key Technical Benchmark,2017-09-28 07:00:00 +0000,http://finance.yahoo.com/r/82133dc1-019f-346f-b426-b2c7bc731198/nevro-trying-to-close-in-on-key-technical-benchmark?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Nevro shows improving technical performance. Will it continue?
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-09-26 12:03:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120356679.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
NVRO,NVRO:US,BBG001K61W36,Nevro Gets Relative Strength Rating Upgrade,2017-09-14 07:00:00 +0000,http://finance.yahoo.com/r/e5751cdc-06f7-3dba-bb8a-ff63d4838eb6/nevro-gets-relative-strength-rating-upgrade?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Nevro shows improving technical performance. Will it continue?
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-09-11 14:08:44 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140844708.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
NVRO,NVRO:US,BBG001K61W36,Stocks Generating Improved Relative Strength: Nevro,2017-09-11 07:00:00 +0000,http://finance.yahoo.com/r/c758d93d-00dd-3801-aeca-9587fc766550/stocks-generating-improved-relative-strength-nevro?src=A00220&yptr=yahoo&.tsrc=rss,"Nevro shows improving price performance, earning an upgrade to its IBD Relative Strength Rating"
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-09-07 12:03:27 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120327638.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at Upcoming Investor Conferences,2017-08-24 20:09:00 +0000,https://finance.yahoo.com/news/nevro-present-upcoming-investor-conferences-200900772.html?.tsrc=rss,"REDWOOD CITY, Calif. , Aug. 24, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-08-22 12:05:08 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120508274.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
NVRO,NVRO:US,BBG001K61W36,Earnings Review and Free Research Report: ResMed Adjusted Diluted EPS Increased 4%,2017-08-16 11:10:00 +0000,https://finance.yahoo.com/news/earnings-review-free-research-report-111000245.html?.tsrc=rss,"Research Desk Line-up: Nevro Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 16, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on ResMed Inc. (NYSE: RMD ), which can ..."
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-08-15 12:04:20 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120420495.html?.tsrc=rss,Short interest is moderately high for NVRO with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  ETFs that hold NVRO had net inflows of $43 million over the last one-month.
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-08-14 12:04:06 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120408917.html?.tsrc=rss,"Short interest is moderately high for NVRO with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding NVRO totaled $149 million."
NVRO,NVRO:US,BBG001K61W36,See what the IHS Markit Score report has to say about Nevro Corp.,2017-08-12 12:01:39 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120139611.html?.tsrc=rss,"Short interest is moderately high for NVRO with between 10 and 15% of shares outstanding currently on loan.  ETFs that hold NVRO had net inflows of $5 million over the last one-month.  Index (PMI) data, output in the Healthcare sector is rising."
NVRO,NVRO:US,BBG001K61W36,Edited Transcript of NVRO earnings conference call or presentation 7-Aug-17 8:30pm GMT,2017-08-12 07:55:47 +0000,https://finance.yahoo.com/news/edited-transcript-nvro-earnings-conference-024324671.html?.tsrc=rss,Q2 2017 Nevro Corp Earnings Call
NVRO,NVRO:US,BBG001K61W36,"Nevro's (NVRO) Q2 Loss Wider than Expected, Revenues Beat",2017-08-10 15:40:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ICNkJgDdFY/nevros-nvro-q2-loss-wider-than-expected-revenues-beat-cm830191,Nevro Corp 160 NVRO reported second quarter 2017 loss per share of 40 cents comparing unfavorably with a loss of 27 cents per share in the year ago quarter This figure was also much wider than the Zacks Consensus Estimate of a loss of 29 cents Revenues in the reported quarter however
NVRO,NVRO:US,BBG001K61W36,"Nevro&apos;s (NVRO) Q2 Loss Wider than Expected, Revenues Beat",2017-08-10 13:49:01 +0000,https://finance.yahoo.com/news/nevro-apos-nvro-q2-loss-134901688.html?.tsrc=rss,Nevro&apos;s (NVRO) topline gains on continued global adoption of HF10 therapy. Rising operating expenses are major concerns.
NVRO,NVRO:US,BBG001K61W36,IHS Markit Score Update: Drop in demand for ETFs holding Nevro Corp is a negative sign for its shares,2017-08-10 12:01:52 +0000,https://finance.yahoo.com/news/ihs-markit-score-drop-demand-120152407.html?.tsrc=rss,"Short interest is moderately high for NVRO with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding NVRO totaled $435 million."
NVRO,NVRO:US,BBG001K61W36,NVRO Makes Bullish Cross Above Critical Moving Average,2017-08-08 16:39:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LCPJzg7uD0Q/nvro-makes-bullish-cross-above-critical-moving-average-cm828804,In trading on Tuesday shares of Nevro Corp Symbol NVRO crossed above their 200 day moving average of 84 42 changing hands as high as 88 24 per share Nevro Corp shares are currently trading up about 3 7 on the day The chart below shows the one year performance of NVRO shares versus
NVRO,NVRO:US,BBG001K61W36,Nevro reports 2Q loss,2017-08-08 04:00:34 +0000,https://finance.yahoo.com/news/nevro-reports-2q-loss-203254344.html?.tsrc=rss,"On a per-share basis, the Redwood City, California-based company said it had a loss of 40 cents. The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Second Quarter 2017 Financial Results,2017-08-07 20:14:00 +0000,https://finance.yahoo.com/news/nevro-reports-second-quarter-2017-201400570.html?.tsrc=rss,"REDWOOD CITY, Calif. , Aug. 7, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Investor Network: Nevro Corp. to Host Earnings Call,2017-08-07 10:40:00 +0000,https://finance.yahoo.com/news/investor-network-nevro-corp-host-104000196.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 7, 2017 / Nevro Corp. (NYSE: NVRO) will be discussing their earnings results in their Q2 Earnings Call to be held on Monday, August 07, 2017 at 4:30 PM Eastern Time. ..."
NVRO,NVRO:US,BBG001K61W36,Should You Buy Nevro (NVRO) Ahead of Earnings?,2017-08-03 15:05:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BRcQV_NHdaw/should-you-buy-nevro-nvro-ahead-of-earnings-cm826406,Investors are always looking for stocks that are poised to beat at earnings season and Nevro Corp NVRO may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Nevro is seeing favorable earnings
NVRO,NVRO:US,BBG001K61W36,Should You Buy Nevro (NVRO) Ahead of Earnings?,2017-08-03 12:59:12 +0000,https://finance.yahoo.com/news/buy-nevro-nvro-ahead-earnings-125912393.html?.tsrc=rss,"Nevro (NVRO) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the Canaccord Genuity Growth Conference,2017-07-26 20:10:00 +0000,https://finance.yahoo.com/news/nevro-present-canaccord-genuity-growth-201000608.html?.tsrc=rss,"REDWOOD CITY, Calif. , July 26, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Second Quarter 2017,2017-07-24 20:09:00 +0000,https://finance.yahoo.com/news/nevro-report-operating-results-second-200900699.html?.tsrc=rss,"Nevro to Host Conference Call on Monday, August 7, 2017 at 1:30 p.m. PT / 4:30 p.m. ET REDWOOD CITY, Calif. , July 24, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Corp (NVRO) Shares Cross Above 200 DMA,2017-07-13 21:48:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LGhA0qmYH30/nevro-corp-nvro-shares-cross-above-200-dma-cm815877,In trading on Thursday shares of Nevro Corp Symbol NVRO crossed above their 200 day moving average of 85 89 changing hands as high as 86 35 per share Nevro Corp shares are currently trading up about 2 4 on the day The chart below shows the one year performance of NVRO shares versus
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : July 7, 2017",2017-07-07 19:18:14 +0000,http://finance.yahoo.com/r/74f66cc3-7786-3019-8177-3b1a3bfc3260/etfs-with-exposure-to-nevro-corp-july-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO) Surges: Stock Moves 11.4% Higher,2017-07-06 14:49:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7SMjNuAVIKQ/nevro-nvro-surges-stock-moves-114-higher-cm812322,Nevro Corp NVRO was a big mover last session as the company saw its shares rise over 11 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the volatile
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO) Surges: Stock Moves 11.4% Higher,2017-07-06 12:48:12 +0000,https://finance.yahoo.com/news/nevro-nvro-surges-stock-moves-124812540.html?.tsrc=rss,"Nevro (NVRO) was a big mover last session, as the company saw its shares rise over 11% on the day."
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : July 6, 2017",2017-07-06 12:20:42 +0000,http://finance.yahoo.com/r/0c9129ef-0e3f-3c48-bfae-4ad84a4b3210/nevro-corp-breached-its-50-day-moving-average-in-a-bullish-manner-nvro-us-july-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Nevro Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM...",2017-07-05 22:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-sOasuVpC4g/gainers--losers-of-july-5-cala-nvro-bpmc-kmph-fldm-20170705-01206,"Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM..."
NVRO,NVRO:US,BBG001K61W36,Here's Why Shares of Nevro Corp. (NVRO) Jumped Today,2017-07-05 20:44:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pXQakU7gwOA/heres-why-shares-of-nevro-corp-nvro-jumped-today-cm812049,Shares of Nevro Corp NVRO climbed 10 in midday trading Wednesday after the company reported preliminary sales numbers for the second quarter of fiscal year 2017 Nevro a medical device company that serves patients living with chronic pain said it expects to post revenues of 77 5 million
NVRO,NVRO:US,BBG001K61W36,Here&apos;s Why Shares of Nevro Corp. (NVRO) Jumped Today,2017-07-05 19:02:07 +0000,https://finance.yahoo.com/news/apos-why-shares-nevro-corp-190207982.html?.tsrc=rss,Shares of Nevro Corp. NVRO) climbed 10% in midday trading Wednesday after the company reported preliminary sales numbers for the second quarter of fiscal year 2017.
NVRO,NVRO:US,BBG001K61W36,Why Nevro Corp. Is Soaring 10% Higher Today,2017-07-05 18:46:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oe1UN16BqcM/why-nevro-corp-is-soaring-10-higher-today-cm812000,What happened Shares in Nevro Corp NYSE NVRO are rallying 10 5 at 12 30 p m EDT 160 after the company gave investors an early peek at its second quarter financials So what The company is knee deep in growth mode following the launch of Senza in 2015 a device that
NVRO,NVRO:US,BBG001K61W36,"Health Care Sector Update for 07/05/2017: NVRO,MTBC,BGNE",2017-07-05 18:23:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xw84EK0yhBo/health-care-sector-update-for-07052017-nvromtbcbgne-cm812016,Top Health Care StocksTop Health Care Stocks JNJ 0 43 JNJ 0 43 PFE 0 65 PFE 0 65 ABT 0 56 ABT 0 56 MRK 0 36 MRK 0 36 AMGN 0 53 AMGN 0 53 Health care stocks were holding moderate gains with the NYSE Health Care Index climbing about 0 1 while shares of health care companies in
NVRO,NVRO:US,BBG001K61W36,Why Nevro Corp. Is Soaring 10% Higher Today,2017-07-05 17:12:00 +0000,http://finance.yahoo.com/r/02ae2e1d-edda-34f9-8458-4f980fc60c31/why-nevro-corp-is-soaring-10-higher-today.aspx?yptr=yahoo&.tsrc=rss,The company announced preliminary second-quarter financials that are reassuring investors.
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Preliminary Unaudited Second Quarter 2017 Revenue and Business Update,2017-07-05 10:59:00 +0000,https://finance.yahoo.com/news/nevro-announces-preliminary-unaudited-second-105900129.html?.tsrc=rss,"REDWOOD CITY, Calif., July 5, 2017 /PRNewswire/ -- Nevro Corp. (NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced its preliminary unaudited revenue for the second quarter ended June 30, 2017.  The company announced that preliminary unaudited second quarter worldwide revenue is expected to be in the range of $77.5 to $78.0 million, compared to $55.4 million in the second quarter of 2016.  The company expects worldwide revenue for the full year 2017 to be in the range of $310.0 to $320.0 million."
NVRO,NVRO:US,BBG001K61W36,Nevro Corp. (NVRO) Is Climbing On Q2 Revenue Forecast,2017-07-05 09:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wkzyMKMnWhY/nevro-corp-nvro-is-climbing-on-q2-revenue-forecast-20170705-00625,Nevro Corp. (NVRO) Is Climbing On Q2 Revenue Forecast
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : June 26, 2017",2017-06-26 20:34:48 +0000,http://finance.yahoo.com/r/d3da6ddb-88c7-333e-8614-91b36741dff6/etfs-with-exposure-to-nevro-corp-june-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : June 16, 2017",2017-06-16 20:07:09 +0000,http://finance.yahoo.com/r/b0da1f71-fb37-3f97-8ac6-f4108ac96c3b/etfs-with-exposure-to-nevro-corp-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,Neurosurgery Selects the SENZA-RCT 24-Month Outcomes Publication as the Top Pain Paper of the Year,2017-06-15 22:45:00 +0000,https://finance.yahoo.com/news/neurosurgery-selects-senza-rct-24-224500741.html?.tsrc=rss,"REDWOOD CITY, Calif., June 15, 2017 /PRNewswire/ -- Nevro Corp. (NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that Neurosurgery, the official journal of the Congress of Neurological Surgeons (CNS), selected the SENZA-RCT 24-month outcomes publication as the journal's Top Pain Paper of the Year.  The SENZA-RCT is a groundbreaking pivotal study that was both the largest prospective randomized clinical trial ever conducted to assess the treatment of chronic back and leg pain, and the first to evaluate comparative effectiveness of spinal cord stimulation (SCS) therapies.  Each paper was subject to a rigorous review process with the journal's editorial board, beginning with initial selection from the entire pool of papers published between June 2016 and June 2017.  ""The CNS is committed to providing relevant and informative science to our members."
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. :NVRO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017",2017-06-14 13:52:55 +0000,http://finance.yahoo.com/r/24f117c5-c38b-3982-9d3c-501836a30817/nevro-corp-nvro-us-earnings-analysis-q1-2017-by-the-numbers-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Nevro Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Nevro Corp. – ABIOMED, Inc., Thermo Fisher Scientific Inc., Intuitive Surgical, Inc. and Orthofix International NV (ABMD-US, TMO-US, ISRG-US and OFIX-US) that have also reported for this period. Highlights ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,Relative Strength Alert For Nevro,2017-05-31 17:31:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cHdO9rz2WOk/relative-strength-alert-for-nevro-cm796937,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the William Blair Growth Stock Conference,2017-05-30 20:10:00 +0000,https://finance.yahoo.com/news/nevro-present-william-blair-growth-201000147.html?.tsrc=rss,"REDWOOD CITY, Calif., May 30, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Edited Transcript of NVRO earnings conference call or presentation 8-May-17 8:30pm GMT,2017-05-14 01:15:53 +0000,https://finance.yahoo.com/news/edited-transcript-nvro-earnings-conference-011330052.html?.tsrc=rss,Q1 2017 Nevro Corp Earnings Call
NVRO,NVRO:US,BBG001K61W36,Biotech And Pharma Industry And Stock News,2017-05-10 19:02:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
NVRO,NVRO:US,BBG001K61W36,Edited Transcript of NVRO earnings conference call or presentation 8-May-17 8:30pm GMT,2017-05-10 00:06:14 +0000,http://finance.yahoo.com/news/edited-transcript-nvro-earnings-conference-011330052.html?.tsrc=rss,Q1 2017 Nevro Corp Earnings Call
NVRO,NVRO:US,BBG001K61W36,Nevro Corp. Just Tumbled By As Much As 12% -- Here's Why,2017-05-09 21:03:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qRiOYwZ19pI/nevro-corp-just-tumbled-by-as-much-as-12-heres-why-cm786817,What happened Shares of Nevro NYSE NVRO a medical device developer and manufacturer with a specific focus on providing relief to chronic pain sufferers tumbled as much as 12 on Tuesday following the release of its first quarter earnings results after the closing bell
NVRO,NVRO:US,BBG001K61W36,Medtech Player Losses Double That Of Views; Shares Tumble,2017-05-09 20:26:57 +0000,http://finance.yahoo.com/r/2133a80c-9e76-30ad-a7ee-b5dfc41e034c/why-you-should-buy-aggressively-shares-of-this-medtech-player?src=A00220&yptr=yahoo&.tsrc=rss,Nevro stock collapsed after the medtech player reported first-quarter losses that were double what analysts predicted.
NVRO,NVRO:US,BBG001K61W36,Nevro Corp. Just Tumbled By As Much As 12% -- Here&apos;s Why,2017-05-09 19:22:00 +0000,http://finance.yahoo.com/r/4f3249d9-14f2-3ad3-8bf1-8045ba1e5117/nevro-corp-just-tumbled-by-as-much-as-12-heres-why.aspx?yptr=yahoo&.tsrc=rss,"For a second straight quarter, Nevro&apos;s bottom-line results miss by a mile."
NVRO,NVRO:US,BBG001K61W36,Oversold Conditions For Nevro (NVRO),2017-05-09 18:03:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XR3H_lUOS4g/oversold-conditions-for-nevro-nvro-cm786656,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
NVRO,NVRO:US,BBG001K61W36,Nevro reports 1Q loss,2017-05-08 20:21:07 +0000,http://finance.yahoo.com/news/nevro-reports-1q-loss-202107470.html?.tsrc=rss,"On a per-share basis, the Redwood City, California-based company said it had a loss of 50 cents. The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Reports First Quarter 2017 Financial Results,2017-05-08 20:10:00 +0000,http://finance.yahoo.com/news/nevro-reports-first-quarter-2017-201000126.html?.tsrc=rss,"REDWOOD CITY, Calif., May 8, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"Medical Product Q1 Earnings on May 8: ITGR, OPK & More",2017-05-05 15:29:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U88060y8hzM/medical-product-q1-earnings-on-may-8-itgr-opk-more-cm784917,The Q1 reporting cycle is at its last lap with 358 S amp P members 78 2 of the total market cap having already reported their quarterly numbers For Medical one of the 16 broader Zacks sectors we have results from 84 5 of total market cap Per the latest Earnings Outlook so far
NVRO,NVRO:US,BBG001K61W36,"Medical Product Q1 Earnings on May 8: ITGR, OPK & More",2017-05-05 13:33:01 +0000,http://finance.yahoo.com/news/medical-product-q1-earnings-may-133301117.html?.tsrc=rss,Let&apos;s take a look at the major Medical products stocks slated to release their first-quarter 2017 reports on May 8.
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the Bank of America Merrill Lynch 2017 Health Care Conference,2017-05-02 20:10:00 +0000,http://finance.yahoo.com/news/nevro-present-bank-america-merrill-201000092.html?.tsrc=rss,"REDWOOD CITY, Calif., May 2, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. – Value Analysis (NYSE:NVRO) : May 1, 2017",2017-05-01 21:14:25 +0000,http://finance.yahoo.com/r/56adb143-0889-3dec-8d7d-2def9c0284ff/nevro-corp-value-analysis-nysenvro-may-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Nevro Corp. a score of 31. Our analysis is based on comparing Nevro Corp. with the following peers – ABIOMED, Inc., Thermo Fisher Scientific Inc., Intuitive Surgical, Inc. and Orthofix International NV (ABMD-US, TMO-US, ISRG-US and OFIX-US). Investment Outlook Nevro Corp. has a fundamental score of 31 ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : April 28, 2017",2017-04-28 12:20:32 +0000,http://finance.yahoo.com/r/5c59a812-a129-32e4-8291-b407d0b849cc/nevro-corp-breached-its-50-day-moving-average-in-a-bullish-manner-nvro-us-april-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Nevro Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the First Quarter 2017,2017-04-24 20:10:00 +0000,http://finance.yahoo.com/news/nevro-report-operating-results-first-201000077.html?.tsrc=rss,"REDWOOD CITY, Calif., April 24, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : April 21, 2017",2017-04-21 19:02:09 +0000,http://finance.yahoo.com/r/8a285dfc-a1d1-3076-a0cd-a4573de7642d/etfs-with-exposure-to-nevro-corp-april-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,Nevro Becomes Oversold (NVRO),2017-04-12 17:54:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kEpuSDOZlBk/nevro-becomes-oversold-nvro-cm773363,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
NVRO,NVRO:US,BBG001K61W36,Notable Two Hundred Day Moving Average Cross - NVRO,2017-04-12 16:56:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ef2eDPlHTeQ/notable-two-hundred-day-moving-average-cross-nvro-cm773329,In trading on Wednesday shares of Nevro Corp Symbol NVRO crossed below their 200 day moving average of 88 58 changing hands as low as 88 17 per share Nevro Corp shares are currently trading down about 1 4 on the day The chart below shows the one year performance of NVRO shares versus
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : April 7, 2017",2017-04-07 21:11:55 +0000,http://finance.yahoo.com/r/0729097f-0c05-317f-9d50-35610ef8442b/etfs-with-exposure-to-nevro-corp-april-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : April 6, 2017",2017-04-06 12:29:56 +0000,http://finance.yahoo.com/r/e9e3fc27-b6ca-37d0-9e68-5e1fa771f0f0/nevro-corp-breached-its-50-day-moving-average-in-a-bearish-manner-nvro-us-april-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Nevro Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Commit To Purchase Nevro Corp At $75, Earn 10.2% Annualized Using Options",2017-03-27 16:02:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yO03M7Sxogo/commit-to-purchase-nevro-corp-at-75-earn-102-annualized-using-options-cm766017,Investors eyeing a purchase of Nevro Corp Symbol NVRO shares but cautious about paying the going market price of 93 15 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the November put at
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : March 27, 2017",2017-03-27 12:07:06 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-breached-its-50-day-moving-average-in-a-bullish-manner-nvro-us-march-27-2017/,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : March 27, 2017"
NVRO,NVRO:US,BBG001K61W36,NEVRO CORP Financials,2017-03-01 18:04:11 +0000,http://finance.yahoo.com/q/is?s=nvro,NEVRO CORP Financials
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. :NVRO-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017",2017-02-28 18:18:35 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-nvro-us-earnings-analysis-2016-by-the-numbers-february-28-2017/,"Nevro Corp. :NVRO-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. :NVRO-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017",2017-02-28 18:18:35 +0000,http://finance.yahoo.com/r/1c251518-fc94-31b0-a7d8-835539b04266/nevro-corp-nvro-us-earnings-analysis-2016-by-the-numbers-february-28-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Nevro Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Nevro Corp. – Intuitive Surgical, Inc., ABIOMED, Inc. and Thermo Fisher Scientific Inc. (ISRG-US, ABMD-US and TMO-US) that have also reported for this period. Highlights Gross margins widened from ... Read more    
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. :NVRO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27, 2017",2017-02-27 15:20:16 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-nvro-us-earnings-analysis-q4-2016-by-the-numbers-february-27-2017/,"Nevro Corp. :NVRO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27, 2017"
NVRO,NVRO:US,BBG001K61W36,Edited Transcript of NVRO earnings conference call or presentation 23-Feb-17 9:30pm GMT,2017-02-24 01:13:38 +0000,http://finance.yahoo.com/news/edited-transcript-nvro-earnings-conference-011338566.html?.tsrc=rss,Q4 2016 Nevro Corp Earnings Call
NVRO,NVRO:US,BBG001K61W36,Edited Transcript of NVRO earnings conference call or presentation 23-Feb-17 9:30pm GMT,2017-02-24 01:13:38 +0000,http://finance.yahoo.com/news/edited-transcript-nvro-earnings-conference-011338566.html,Edited Transcript of NVRO earnings conference call or presentation 23-Feb-17 9:30pm GMT
NVRO,NVRO:US,BBG001K61W36,Nevro reports 4Q loss,2017-02-23 21:26:49 +0000,http://finance.yahoo.com/news/nevro-reports-4q-loss-212649903.html?.tsrc=rss,"The Redwood City, California-based company said it had a loss of 34 cents per share. The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment ..."
NVRO,NVRO:US,BBG001K61W36,Nevro reports 4Q loss,2017-02-23 21:26:49 +0000,http://sg.finance.yahoo.com/news/nevro-reports-4q-loss-212649050.html,Nevro reports 4Q loss
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2017-02-23 21:18:20 +0000,http://biz.yahoo.com/e/170223/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
NVRO,NVRO:US,BBG001K61W36,"4:18 pm Nevro misses by $0.14, beats on revs; guides FY17 revs in-line",2017-02-23 21:18:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#nvro,"4:18 pm Nevro misses by $0.14, beats on revs; guides FY17 revs in-line"
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook,2017-02-23 21:10:00 +0000,http://finance.yahoo.com/news/nevro-reports-fourth-quarter-full-211000655.html?.tsrc=rss,"REDWOOD CITY, Calif., Feb. 23, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook,2017-02-23 21:10:00 +0000,http://finance.yahoo.com/news/nevro-reports-fourth-quarter-full-211000655.html,"[PR Newswire] - REDWOOD CITY, Calif., Feb. 23, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Q4 2016 Nevro Corp Earnings Release - After Market Close,2017-02-23 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20170223.html?t=nvro,Q4 2016 Nevro Corp Earnings Release - After Market Close
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Fourth Quarter and Full Year 2016,2017-02-09 21:10:00 +0000,http://finance.yahoo.com/news/nevro-report-operating-results-fourth-211000796.html?.tsrc=rss,"REDWOOD CITY, Calif., Feb. 9, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Fourth Quarter and Full Year 2016,2017-02-09 21:10:00 +0000,http://finance.yahoo.com/news/nevro-report-operating-results-fourth-211000796.html,"[PR Newswire] - REDWOOD CITY, Calif., Feb. 9, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Analysts Expect IHI To Hit $156,2017-01-30 15:33:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tTNW7U7Fvt8/analysts-expect-ihi-to-hit-156-cm740063,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
NVRO,NVRO:US,BBG001K61W36,Nevro upgraded by Northland Capital,2017-01-30 15:21:53 +0000,http://finance.yahoo.com/q/ud?s=NVRO,Nevro upgraded by Northland Capital
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : January 25, 2017",2017-01-25 18:27:13 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nevro-corp-january-25-2017/,"ETFs with exposure to Nevro Corp. : January 25, 2017"
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : January 25, 2017",2017-01-25 18:27:13 +0000,http://finance.yahoo.com/r/82b7c4d1-cadb-3727-b622-e5c2883b0bdd/etfs-with-exposure-to-nevro-corp-january-25-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more    
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. – Value Analysis (NYSE:NVRO) : January 11, 2017",2017-01-11 16:22:43 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-value-analysis-nysenvro-january-11-2017/,"Nevro Corp. – Value Analysis (NYSE:NVRO) : January 11, 2017"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. – Value Analysis (NYSE:NVRO) : January 11, 2017",2017-01-11 16:22:43 +0000,http://finance.yahoo.com/r/79ddcfe0-3cb8-3520-964c-e6ad969ec809/nevro-corp-value-analysis-nysenvro-january-11-2017?yptr=yahoo&.tsrc=rss,"Categories:   Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Nevro Corp. a score of 25. Our analysis is based on comparing Nevro Corp. with the following peers – Intuitive Surgical, Inc., ABIOMED, Inc., Thermo Fisher Scientific Inc. and Orthofix International NV (ISRG-US, ABMD-US, TMO-US and OFIX-US). Investment Outlook Nevro Corp. has a fundamental score of 25 ... Read more    
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : January 10, 2017",2017-01-10 12:21:51 +0000,http://finance.yahoo.com/r/84186e77-2574-3485-9d2a-5e2b4213f1b2/nevro-corp-breached-its-50-day-moving-average-in-a-bullish-manner-nvro-us-january-10-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Nevro Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : January 10, 2017",2017-01-10 12:21:51 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-breached-its-50-day-moving-average-in-a-bullish-manner-nvro-us-january-10-2017/,"Nevro Corp. breached its 50 day moving average in a Bullish Manner : NVRO-US : January 10, 2017"
NVRO,NVRO:US,BBG001K61W36,NVRO Crosses Above Key Moving Average Level,2017-01-09 18:49:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ijknZc8AyNA/nvro-crosses-above-key-moving-average-level-cm731193,In trading on Monday shares of Nevro Corp Symbol NVRO crossed above their 200 day moving average of 80 28 changing hands as high as 81 00 per share Nevro Corp shares are currently trading up about 2 9 on the day The chart below shows the one year performance of NVRO shares versus its
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Change in Directors or Principal Officers",2017-01-04 21:32:00 +0000,http://biz.yahoo.com/e/170104/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Change in Directors or Principal Officers"
NVRO,NVRO:US,BBG001K61W36,St. Jude’s Proclaim Elite SCS System Received CE Mark Approval,2016-12-30 17:35:29 +0000,http://marketrealist.com/2016/12/st-judes-proclaim-elite-scs-system-received-ce-mark-approval/?utm_source=yahoo&utm_medium=feed,St. Jude’s Proclaim Elite SCS System Received CE Mark Approval
NVRO,NVRO:US,BBG001K61W36,St. Jude’s Proclaim Elite SCS System Received CE Mark Approval,2016-12-30 17:35:29 +0000,http://finance.yahoo.com/r/f5a58d5b-9bfa-3c06-a944-d85c99bff3b1/st-judes-proclaim-elite-scs-system-received-ce-mark-approval?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On December 8, 2016, St. Jude Medical (STJ) announced CE Mark approval for full body MR (magnetic resonance) conditional labeling for the Proclaim Elite SCS (spinal cord stimulation) System."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the 35th Annual J.P. Morgan Healthcare Conference,2016-12-22 21:10:00 +0000,http://finance.yahoo.com/news/nevro-present-35th-annual-j-211000594.html,"[PR Newswire] - REDWOOD CITY, Calif., Dec. 22, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the 35th Annual J.P. Morgan Healthcare Conference,2016-12-22 21:10:00 +0000,http://finance.yahoo.com/news/nevro-present-35th-annual-j-211000594.html?.tsrc=rss,"REDWOOD CITY, Calif., Dec. 22, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation",2016-12-20 21:46:28 +0000,http://biz.yahoo.com/e/161220/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation"
NVRO,NVRO:US,BBG001K61W36,Time to Focus on Nevro (NVRO) for Strong Earnings Growth Potential,2016-12-13 18:56:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LNBk3NES-4o/time-to-focus-on-nevro-nvro-for-strong-earnings-growth-potential-cm720878,Growth stocks can be some of the most exciting picks in the market as these high flyers can captivate investors attention and produce big gains as well However these can also lead on the downside when the growth story is over so it is important to find companies which are still seeing
NVRO,NVRO:US,BBG001K61W36,Time to Focus on Nevro (NVRO) for Strong Earnings Growth Potential,2016-12-13 16:43:04 +0000,http://finance.yahoo.com/news/time-focus-nevro-nvro-strong-164304495.html?.tsrc=rss,"Nevro (NVRO) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective."
NVRO,NVRO:US,BBG001K61W36,Time to Focus on Nevro (NVRO) for Strong Earnings Growth Potential,2016-12-13 16:43:04 +0000,http://finance.yahoo.com/news/time-focus-nevro-nvro-strong-164304495.html,Time to Focus on Nevro (NVRO) for Strong Earnings Growth Potential
NVRO,NVRO:US,BBG001K61W36,[$$] Is Boston Scientific Nervous About Nevro?,2016-12-13 12:35:00 +0000,http://www.barrons.com/articles/is-boston-scientific-nervous-about-nevro-1481632512?mod=yahoobarrons&ru=yahoo,[$$] Is Boston Scientific Nervous About Nevro?
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Filing of Lawsuit by Boston Scientific,2016-12-09 22:22:00 +0000,http://finance.yahoo.com/news/nevro-announces-filing-lawsuit-boston-222200861.html,"[PR Newswire] - REDWOOD CITY, Calif., Dec. 9, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Filing of Lawsuit by Boston Scientific,2016-12-09 22:22:00 +0000,http://finance.yahoo.com/news/nevro-announces-filing-lawsuit-boston-222200861.html?.tsrc=rss,"REDWOOD CITY, Calif., Dec. 9, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Other Events",2016-12-09 22:18:10 +0000,http://biz.yahoo.com/e/161209/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Other Events"
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : December 9, 2016",2016-12-09 17:30:59 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nevro-corp-december-9-2016/,"ETFs with exposure to Nevro Corp. : December 9, 2016"
NVRO,NVRO:US,BBG001K61W36,"ETFs with exposure to Nevro Corp. : December 9, 2016",2016-12-09 17:30:59 +0000,http://finance.yahoo.com/r/a5cdda79-0684-314b-b4e1-939ae937c362/etfs-with-exposure-to-nevro-corp-december-9-2016?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Nevro Corp. Here are 5 ETFs with the largest exposure to NVRO-US. Comparing the performance and risk of Nevro Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more    
<b>(Read more...)</b>"
NVRO,NVRO:US,BBG001K61W36,Should Nevro (NVRO) Be On Your Radar Now?,2016-12-05 13:55:01 +0000,http://finance.yahoo.com/news/nevro-nvro-radar-now-135501758.html,Should Nevro (NVRO) Be On Your Radar Now?
NVRO,NVRO:US,BBG001K61W36,Nevro Lawsuit against BSX Could Impact Its Neuromodulation Revenues,2016-12-01 15:05:51 +0000,http://marketrealist.com/2016/11/nevro-lawsuit-against-bsx-could-impact-its-neuromodulation-revenues/?utm_source=yahoo&utm_medium=feed,Nevro Lawsuit against BSX Could Impact Its Neuromodulation Revenues
NVRO,NVRO:US,BBG001K61W36,RSI Alert: Nevro (NVRO) Now Oversold,2016-11-30 18:54:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DKfPY4i2KGo/rsi-alert-nevro-nvro-now-oversold-cm715858,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
NVRO,NVRO:US,BBG001K61W36,Notable Two Hundred Day Moving Average Cross - NVRO,2016-11-30 17:53:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yNAAg-6ZRMc/notable-two-hundred-day-moving-average-cross-nvro-cm715792,In trading on Wednesday shares of Nevro Corp Symbol NVRO crossed below their 200 day moving average of 78 11 changing hands as low as 75 30 per share Nevro Corp shares are currently trading off about 4 4 on the day The chart below shows the one year performance of NVRO shares versus
NVRO,NVRO:US,BBG001K61W36,"Boston Scientific Hit With Patent Lawsuit (BSX, NVRO)",2016-11-29 21:02:00 +0000,http://www.investopedia.com/news/nevro-files-patent-suit-vs-boston-scientific-bsx-nvro/?partner=YahooSA,"Boston Scientific Hit With Patent Lawsuit (BSX, NVRO)"
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Other Events",2016-11-29 11:06:05 +0000,http://biz.yahoo.com/e/161129/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Other Events"
NVRO,NVRO:US,BBG001K61W36,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX",2016-11-29 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_blUfWqs7IM/fold-shrinks-jazz-on-right-track-nvls-choked-up-aaap-on-watch-nvro-sues-bsx-20161129-00005,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX"
NVRO,NVRO:US,BBG001K61W36,Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S.,2016-11-28 23:25:00 +0000,http://finance.yahoo.com/news/nevro-files-lawsuit-patent-infringement-232500349.html?.tsrc=rss,"REDWOOD CITY, Calif., Nov. 28, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S.,2016-11-28 23:25:00 +0000,http://finance.yahoo.com/news/nevro-files-lawsuit-patent-infringement-232500349.html,"[PR Newswire] - REDWOOD CITY, Calif., Nov. 28, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Files Patent Infringement Lawsuit Against Units Of Boston Scientific,2016-11-28 19:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jDasnzdjXIs/nevro-files-patent-infringement-lawsuit-against-units-of-boston-scientific-20161128-00948,Nevro Files Patent Infringement Lawsuit Against Units Of Boston Scientific
NVRO,NVRO:US,BBG001K61W36,Are Investors Right To Be Bullish On Nevro Corp (NVRO)?,2016-11-23 17:53:48 +0000,http://www.insidermonkey.com/blog/are-investors-right-to-be-bullish-on-nevro-corp-nvro-490244/,Are Investors Right To Be Bullish On Nevro Corp (NVRO)?
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Change in Directors or Principal Officers",2016-11-22 22:03:13 +0000,http://biz.yahoo.com/e/161122/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Change in Directors or Principal Officers"
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree",2016-11-21 22:02:02 +0000,http://biz.yahoo.com/e/161121/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree"
NVRO,NVRO:US,BBG001K61W36,Is Nevro (NVRO) a Great Growth Stock?,2016-11-21 15:52:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dKvTAAu1TCY/is-nevro-nvro-a-great-growth-stock-cm711905,Growth stocks can be some of the most exciting picks in the market as these high flyers can captivate investors attention and produce big gains as well However these can also lead on the downside when the growth story is over so it is important to find companies which are still seeing
NVRO,NVRO:US,BBG001K61W36,Is Nevro (NVRO) a Great Growth Stock?,2016-11-21 13:45:01 +0000,http://finance.yahoo.com/news/nevro-nvro-great-growth-stock-134501811.html,Is Nevro (NVRO) a Great Growth Stock?
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the 28th Annual Piper Jaffray Healthcare Conference,2016-11-15 21:10:00 +0000,http://finance.yahoo.com/news/nevro-present-28th-annual-piper-211000413.html,"[PR Newswire] - REDWOOD CITY, Calif., Nov. 15, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the 28th Annual Piper Jaffray Healthcare Conference,2016-11-15 21:10:00 +0000,http://finance.yahoo.com/news/nevro-present-28th-annual-piper-211000413.html?.tsrc=rss,"REDWOOD CITY, Calif., Nov. 15, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO): An Off-the-Radar Potential Winner,2016-11-14 16:29:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pklijCY5Eqk/nevro-nvro-an-off-the-radar-potential-winner-cm708645,It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out Before they take the plunge others get to know the hidden potential and enter into these stocks pushing them out of reach So instead of repenting spotting
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO): An Off-the-Radar Potential Winner,2016-11-14 14:34:02 +0000,http://finance.yahoo.com/news/nevro-nvro-off-radar-potential-143402028.html,Nevro (NVRO): An Off-the-Radar Potential Winner
NVRO,NVRO:US,BBG001K61W36,"ETF’s with exposure to Nevro Corp. : November 10, 2016",2016-11-10 17:48:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nevro-corp-november-10-2016/,"ETF’s with exposure to Nevro Corp. : November 10, 2016"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. :NVRO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016",2016-11-09 15:56:19 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-nvro-us-earnings-analysis-q3-2016-by-the-numbers-november-9-2016/,"Nevro Corp. :NVRO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016"
NVRO,NVRO:US,BBG001K61W36,"Stock Market Anxiety? It's Not Clinton-Trump, It's The U.S. Federal Reserve",2016-11-09 14:54:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QF7XN7c2RI8/stock-market-anxiety-its-not-clinton-trump-its-the-us-federal-reserve-cm702058,By Gary Gordon ByGary Gordon The financial media rely heavily on advertising sales from financial firms Conflict of interest Possibly If scores of folks make risk off adjustments to portfolios such that the demand for riskier assets e g stocks low grade corporate bonds etc
NVRO,NVRO:US,BBG001K61W36,No Soup For You! Companies Will Slow Down Their Dividend Payouts And Stock Buybacks,2016-11-08 14:59:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h4v8KacsdOo/no-soup-for-you-companies-will-slow-down-their-dividend-payouts-and-stock-buybacks-cm699036,By Gary Gordon ByGary Gordon Public companies seldom distribute more to shareholders than what they earn in a given year It is categorically uncommon for those corporations to pay out more in dividends and share buybacks than what they earn for two years in a row Three years That s
NVRO,NVRO:US,BBG001K61W36,Nevro reports 3Q loss,2016-11-07 23:12:48 +0000,http://sg.finance.yahoo.com/news/nevro-reports-3q-loss-231248538.html,Nevro reports 3Q loss
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-11-07 21:40:03 +0000,http://biz.yahoo.com/e/161107/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Third Quarter 2016 Financial Results,2016-11-07 21:20:00 +0000,http://www.publicnow.com/view/E0A74912AF359BDF76F556334522DDCF0D78314E,"[at noodls] - REDWOOD CITY, Calif., Nov. 7, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Third Quarter 2016 Financial Results,2016-11-07 21:10:00 +0000,http://finance.yahoo.com/news/nevro-reports-third-quarter-2016-211000666.html?.tsrc=rss,"REDWOOD CITY, Calif., Nov. 7, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Cormorant Asset Management’s Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare Stocks Show Strong Returns,2016-11-07 20:23:27 +0000,http://www.insidermonkey.com/blog/cormorant-asset-managements-bets-on-alder-biopharmaceuticals-inc-aldr-and-other-healthcare-stocks-show-strong-returns-485299/,Cormorant Asset Management’s Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare Stocks Show Strong Returns
NVRO,NVRO:US,BBG001K61W36,Q3 2016 Nevro Corp Earnings Release - After Market Close,2016-11-07 12:07:06 +0000,http://biz.yahoo.com/research/earncal/20161107.html?t=nvro,Q3 2016 Nevro Corp Earnings Release - After Market Close
NVRO,NVRO:US,BBG001K61W36,"Medical Product Stocks Nov 7 Earnings Lineup: ALGN NVRO, HAE",2016-11-04 13:19:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Xm-fsY3ubI/medical-product-stocks-nov-7-earnings-lineup-algn-nvro-hae-cm703888,With Q3 earnings reports already out from more than 72 8 of the S amp P 500 members 364 companies our latest Earnings Outlook has exhibited an improving trend so far Proceeding to the last lap of the earnings reporting cycle we are further assured about this quarter being the first
NVRO,NVRO:US,BBG001K61W36,"Medical Product Stocks Nov 7 Earnings Lineup: ALGN NVRO, HAE",2016-11-04 10:57:10 +0000,http://finance.yahoo.com/news/medical-product-stocks-nov-7-105710465.html,"Medical Product Stocks Nov 7 Earnings Lineup: ALGN NVRO, HAE"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : October 27, 2016",2016-10-27 12:30:16 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-breached-its-50-day-moving-average-in-a-bearish-manner-nvro-us-october-27-2016/,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : October 27, 2016"
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Third Quarter 2016,2016-10-24 20:21:08 +0000,http://www.publicnow.com/view/088D5B1D139437CD79FC34F9CAC9BD5347CB2170,"[at noodls] - REDWOOD CITY, Calif., Oct. 24, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Third Quarter 2016,2016-10-24 20:15:00 +0000,http://finance.yahoo.com/news/nevro-report-operating-results-third-201500051.html?.tsrc=rss,"REDWOOD CITY, Calif., Oct. 24, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Exactech Enters Foot & Ankle Space with Vantage System,2016-10-14 15:44:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3X03EdkjUwo/exactech-enters-foot-ankle-space-with-vantage-system-cm693434,Gainesville FL based Exactech Inc EXAC recently announced the first successful surgery using the Vantage Total Ankle System an exclusive platform in the company s extremities product line for treating ankle implants The accomplishment of the surgery marked the successful entry of
NVRO,NVRO:US,BBG001K61W36,Exactech Enters Foot & Ankle Space with Vantage System,2016-10-14 13:33:01 +0000,http://finance.yahoo.com/news/exactech-enters-foot-ankle-space-133301424.html,Exactech Enters Foot & Ankle Space with Vantage System
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO) Now a Strong Buy: Should You Add the Stock?,2016-10-13 14:43:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L4shYMsJBzI/nevro-nvro-now-a-strong-buy-should-you-add-the-stock-cm692744,On Oct 13 Redwood City CA based Nevro Corp Inc NVRO was raised to a Zacks Rank 1 Strong Buy Why the Upgrade The upgrade was primarily driven by solid estimate revisions over the last 60 days The company s estimate revision trend for the current year is impressive with
NVRO,NVRO:US,BBG001K61W36,New Strong Buy Stocks for October 13th,2016-10-13 12:57:12 +0000,http://finance.yahoo.com/news/strong-buy-stocks-october-13th-125712859.html,New Strong Buy Stocks for October 13th
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO) Now a Strong Buy: Should You Add the Stock?,2016-10-13 12:45:12 +0000,http://finance.yahoo.com/news/nevro-nvro-now-strong-buy-124512587.html,Nevro (NVRO) Now a Strong Buy: Should You Add the Stock?
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : October 10, 2016",2016-10-10 12:38:53 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-breached-its-50-day-moving-average-in-a-bearish-manner-nvro-us-october-10-2016/,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : October 10, 2016"
NVRO,NVRO:US,BBG001K61W36,"ETF’s with exposure to Nevro Corp. : October 5, 2016",2016-10-05 14:32:35 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nevro-corp-october-5-2016/,"ETF’s with exposure to Nevro Corp. : October 5, 2016"
NVRO,NVRO:US,BBG001K61W36,Nevro Hits New 52-Week High on Solid HF10 Therapy Sales,2016-09-26 15:25:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Cb4S7k3JRA/nevro-hits-new-52-week-high-on-solid-hf10-therapy-sales-cm684471,Share price of Nevro Corp NVRO rallied to a new 52 week high of 102 66 on Sep 23 eventually closing a bit lower at 102 This represents a stellar one year return of approximately 108 better than the S amp P 500 s 12 over the same period In fact since the last earnings release
NVRO,NVRO:US,BBG001K61W36,Nevro Hits New 52-Week High on Solid HF10 Therapy Sales,2016-09-26 13:05:01 +0000,http://finance.yahoo.com/news/nevro-hits-52-week-high-130501422.html,Nevro Hits New 52-Week High on Solid HF10 Therapy Sales
NVRO,NVRO:US,BBG001K61W36,Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10™ Therapy over Traditional Spinal Cord Stimulation for Chronic Pain,2016-09-06 13:19:09 +0000,http://www.publicnow.com/view/14491371A5355B249BFD11A25720D6623EDF68B8,"[at noodls] - REDWOOD CITY, Calif., Sept. 6, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at Upcoming Investor Conferences,2016-08-25 20:18:04 +0000,http://www.publicnow.com/view/134F448FC8F59F66E14EB3012352734329C9B171,"[at noodls] - REDWOOD CITY, Calif., Aug. 25, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at Upcoming Investor Conferences,2016-08-25 20:10:00 +0000,http://finance.yahoo.com/news/nevro-present-upcoming-investor-conferences-201000859.html?.tsrc=rss,"REDWOOD CITY, Calif., Aug. 25, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at Upcoming Investor Conferences,2016-08-25 20:10:00 +0000,http://finance.yahoo.com/news/nevro-present-upcoming-investor-conferences-201000859.html,"[PR Newswire] - REDWOOD CITY, Calif., Aug. 25, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"ETF’s with exposure to Nevro Corp. : August 24, 2016",2016-08-24 16:09:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nevro-corp-august-24-2016/,"ETF’s with exposure to Nevro Corp. : August 24, 2016"
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders",2016-08-23 10:06:05 +0000,http://biz.yahoo.com/e/160823/nvro8-k_a.html,"NEVRO CORP Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders"
NVRO,NVRO:US,BBG001K61W36,The NVRO Paradox: Analysts Bullish But Forecast -5.45% Fall,2016-08-15 13:34:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r1jibogeg0w/the-nvro-paradox-analysts-bullish-but-forecast-545-fall-cm665186,"Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Nevro Corp (Symbol NVRO). The average 12 month price target for NVRO averaging the work of 9 analysts reveals"
NVRO,NVRO:US,BBG001K61W36,Individual Stocks Doing What Indices Aren't,2016-08-09 20:02:00 +0000,http://realmoney.thestreet.com/articles/08/09/2016/individual-stocks-doing-what-indices-arent?puc=yahoo&cm_ven=YAHOO,Individual Stocks Doing What Indices Aren't
NVRO,NVRO:US,BBG001K61W36,Here's 5 Medical Stocks Soaring After Earnings Today,2016-08-09 19:52:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YHahr4l1Xhc/heres-5-medical-stocks-soaring-after-earnings-today-cm662773,"Second quarter earnings season may be wrapping up, but a plethora of companies in the medical industry were yet to report until this week. Several key drug, biotech, and medical instruments companies reported earnings on Monday and Tuesday, and"
NVRO,NVRO:US,BBG001K61W36,Why Nevro Corp. Is Up Big Today,2016-08-09 18:36:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MSY6tkxk014/why-nevro-corp-is-up-big-today-cm662688,"Image source  Getty Images.  What  Shares of Nevro Corp. (NYSE  NVRO) , a medical device company focused on chronic pain, are up 13% as of 11 50 a.m. EDT in response to"
NVRO,NVRO:US,BBG001K61W36,Here's 5 Medical Stocks Soaring After Earnings Today,2016-08-09 18:36:06 +0000,http://finance.yahoo.com/news/heres-5-medical-stocks-soaring-183606220.html,Here's 5 Medical Stocks Soaring After Earnings Today
NVRO,NVRO:US,BBG001K61W36,Nevro (NVRO) Stock Soars as Q2 Results Beat Expectations,2016-08-09 17:12:00 +0000,https://www.thestreet.com/story/13669961/1/nevro-nvro-stock-soars-as-q2-results-beat-expectations.html?puc=yahoo&cm_ven=YAHOO,Nevro (NVRO) Stock Soars as Q2 Results Beat Expectations
NVRO,NVRO:US,BBG001K61W36,"Health Care Sector Update for 08/09/2016: NVRO,HIIQ,BMRN",2016-08-09 17:08:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xZfZ_6KlWos/health-care-sector-update-for-08092016-nvrohiiqbmrn-cm662653,"Top Health Care Stocks JNJ 0.09% PFE +0.63% MRK +0.09% ABT 0.11% AMGN +0.03% Health care stocks were climbing during Tuesday trade, with the NYSE Health Care Index jumping out to a 0.4% gain and shares of health care"
NVRO,NVRO:US,BBG001K61W36,Nevro Corp (NVRO) Up on Narrower-than-Expected Q2 Loss,2016-08-09 14:39:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L37CbKVhZ2E/nevro-corp-nvro-up-on-narrower-than-expected-q2-loss-cm662439,"Shares of Nevro CorpNVRO surged 9.3% in after hour trading on Aug 8, following the company's second quarter 2016 results. The company reported loss of 31 cents per share, much narrower than the Zacks Consensus Estimate of a loss"
NVRO,NVRO:US,BBG001K61W36,Nevro Corp (NVRO) Up on Narrower-than-Expected Q2 Loss,2016-08-09 12:45:12 +0000,http://finance.yahoo.com/news/nevro-corp-nvro-narrower-expected-124512701.html,Nevro Corp (NVRO) Up on Narrower-than-Expected Q2 Loss
NVRO,NVRO:US,BBG001K61W36,Nevro reports 2Q loss,2016-08-08 21:51:31 +0000,http://sg.finance.yahoo.com/news/nevro-reports-2q-loss-215131493.html,Nevro reports 2Q loss
NVRO,NVRO:US,BBG001K61W36,"Noteworthy Monday Option Activity: FOSL, NVRO, AMBA",2016-08-08 21:18:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mYIuFAhZMQc/noteworthy-monday-option-activity-fosl-nvro-amba-cm662095,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fossil Group Inc (Symbol FOSL), where a total volume of 4,979 contracts has been traded thus far today, a contract volume"
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Second Quarter 2016 Financial Results,2016-08-08 20:39:11 +0000,http://www.publicnow.com/view/D8058587E443167AFDF7F32A3E6DAF147A8E499B,"[at noodls] - REDWOOD CITY, Calif., Aug. 8, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-08-08 20:27:38 +0000,http://biz.yahoo.com/e/160808/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
NVRO,NVRO:US,BBG001K61W36,Q2 2016 Nevro Corp Earnings Release - After Market Close,2016-08-08 11:07:03 +0000,http://biz.yahoo.com/research/earncal/20160808.html?t=nvro,Q2 2016 Nevro Corp Earnings Release - After Market Close
NVRO,NVRO:US,BBG001K61W36,"Medical Product Stocks' Earnings on Aug 8: NVRO, ICUI & More",2016-08-05 12:55:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_oK59R_5aog/medical-product-stocks-earnings-on-aug-8-nvro-icui-more-cm660943,The Q2 earnings season is on its last leg with the results of 414 S&P members already out. At last a sigh of relief for the investors despite all the idiosyncratic notions of the world market that shrouded the
NVRO,NVRO:US,BBG001K61W36,"Medical Product Stocks' Earnings on Aug 8: NVRO, ICUI & More",2016-08-05 11:40:11 +0000,http://finance.yahoo.com/news/medical-product-stocks-earnings-aug-114011204.html,"Medical Product Stocks' Earnings on Aug 8: NVRO, ICUI & More"
NVRO,NVRO:US,BBG001K61W36,"Commit To Buy Nevro Corp At $55, Earn 8.7% Annualized Using Options",2016-07-26 17:25:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zsg54rSRurU/commit-to-buy-nevro-corp-at-55-earn-87-annualized-using-options-cm655004,"Investors eyeing a purchase of Nevro Corp (Symbol NVRO) stock, but tentative about paying the going market price of $79.72 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in"
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Second Quarter 2016,2016-07-25 20:38:07 +0000,http://www.publicnow.com/view/EC377B948DE37705AE220AD1AA830FD06C8F9B22,"[at noodls] - REDWOOD CITY, Calif., July 25, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Strange: Bullish NVRO Analysts Actually See -9.45% Downside,2016-07-15 17:08:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QcTLsbs_VhI/strange-bullish-nvro-analysts-actually-see-945-downside-cm649840,"Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Nevro Corp (Symbol NVRO). The average 12 month price target for NVRO averaging the work of 6 analysts reveals"
NVRO,NVRO:US,BBG001K61W36,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : June 28, 2016",2016-06-28 13:20:04 +0000,http://www.capitalcube.com/blog/index.php/nevro-corp-breached-its-50-day-moving-average-in-a-bearish-manner-nvro-us-june-28-2016/,"Nevro Corp. breached its 50 day moving average in a Bearish Manner : NVRO-US : June 28, 2016"
NVRO,NVRO:US,BBG001K61W36,"ETF’s with exposure to Nevro Corp. : June 24, 2016",2016-06-24 21:41:46 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nevro-corp-june-24-2016/,"ETF’s with exposure to Nevro Corp. : June 24, 2016"
NVRO,NVRO:US,BBG001K61W36,"NEVRO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree",2016-06-13 21:19:00 +0000,http://biz.yahoo.com/e/160613/nvro8-k.html,"NEVRO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree"
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Full Exercise of Over-Allotment Option and Closing of Public Offering of $172.5 Million Convertible Senior Notes,2016-06-13 20:29:05 +0000,http://www.publicnow.com/view/6547C608489ED9DFBE6E75557C9F39EF34A116D6,"[at noodls] - REDWOOD CITY, Calif., June 13, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,How Have IHI’s Mid-Capitalization Stocks Performed?,2016-06-13 15:05:55 +0000,http://marketrealist.com/2016/06/nevros-stock-fell-june-9/?utm_source=yahoo&utm_medium=feed&utm_content=main_permalink&utm_campaign=nevros-stock-fell-june-9,How Have IHI’s Mid-Capitalization Stocks Performed?
NVRO,NVRO:US,BBG001K61W36,"Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others",2016-06-11 19:04:54 +0000,http://www.insidermonkey.com/blog/healthcare-focused-broadfin-capitals-notable-moves-include-cardiovascular-systems-nevro-corp-others-455973/,"Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others"
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the JMP Securities Life Sciences Conference,2016-06-09 20:29:02 +0000,http://www.publicnow.com/view/D2ADC9518BAE7D05262B2F152DBE3E0FB2A4776E,"[at noodls] - REDWOOD CITY, Calif., June 9, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Pricing of Public Offering of $150 Million Convertible Senior Notes,2016-06-08 05:08:03 +0000,http://www.publicnow.com/view/38445D2463E7FB77F557E304771F846168887231,"[at noodls] - REDWOOD CITY, Calif., June 8, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Proposed Public Offering of $125 Million Convertible Senior Notes,2016-06-06 20:28:03 +0000,http://www.publicnow.com/view/231696A0AAB27DCF270C7BE0B1BE4D0D16A9CF38,"[at noodls] - REDWOOD CITY, Calif., June 6, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Stock market shows signs risk-on mentality is back,2016-06-01 19:36:32 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=5CCE323D-7558-4B8F-8BE5-079CB9009B22&siteid=yhoof2,Stock market shows signs risk-on mentality is back
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at Goldman Sachs 37th Annual Global Healthcare Conference,2016-05-26 20:27:02 +0000,http://www.publicnow.com/view/EC3394C5FE0180EA73BA88CF871AC0791698DDC5,"[at noodls] - REDWOOD CITY, Calif., May 26, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains",2016-05-11 14:31:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C_dHiFUt81I/trovagene-trov-q1-loss-wider-than-expected-stock-gains-cm619562,"TrovaGene IncTROV reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year ago loss of 33 cents and Zacks Consensus Estimate of 32 cents. Trovagene Inc. Earnings Surprise | FindTheBest The"
NVRO,NVRO:US,BBG001K61W36,Nevro reports 1Q loss,2016-05-09 21:04:38 +0000,http://sg.finance.yahoo.com/news/nevro-reports-1q-loss-210438841.html,Nevro reports 1Q loss
NVRO,NVRO:US,BBG001K61W36,Nevro Reports First Quarter 2016 Financial Results,2016-05-09 20:38:11 +0000,http://www.publicnow.com/view/16C3839401E00B433C7B123C24DCA2A5A20695D4,"[at noodls] - REDWOOD CITY, Calif., May 9, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,"Med Instruments Stocks' Q1 Earnings: PEN, INGN, OPKO, NVRO",2016-05-06 15:34:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3X5BSSvpSLc/med-instruments-stocks-q1-earnings-pen-ingn-opko-nvro-cm617537,"With more than 374 S&P 500 members having reported their Q1 results, there is some guaranteed good news for investors keen on the Medical sector. As per our latest Earnings Trends report , among the 16 basic Zacks sectors,"
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the First Quarter 2016,2016-04-25 20:24:03 +0000,http://www.publicnow.com/view/8F19BDFE666DF445014ACC0B6D05D26C8A4B780F,"[at noodls] - REDWOOD CITY, Calif., April 25, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Receives FDA Approval for New Surgical Leads for the Senza® Spinal Cord Stimulation System Delivering HF10™ Therapy,2016-04-15 18:37:12 +0000,http://www.publicnow.com/view/DFBE8806554D32A64267D74CC13BE12C3B1F3F35,"[at noodls] - REDWOOD CITY, Calif. , April 15, 2016 /PRNewswire/ -- Nevro Corp. (NYSE:NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Q4 Loss Narrower than Expected; Revenues in Line,2016-03-01 17:30:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2mve4h-OxGI/nevro-q4-loss-narrower-than-expected-revenues-in-line-cm586775,"Nevro Corp.NVRO reported adjusted loss of 5Array cents per share in the fourth quarter of 20Array5, narrower than the Zacks Consensus Estimate of a loss of 54 cents and the year ago loss of 59 cents. The improvement can"
NVRO,NVRO:US,BBG001K61W36,Nevro reports 4Q loss,2016-02-29 21:59:29 +0000,http://sg.finance.yahoo.com/news/nevro-reports-4q-loss-215929233.html,Nevro reports 4Q loss
NVRO,NVRO:US,BBG001K61W36,"After-Hours Earnings Report for February 29, 2016 :  BRX, WDAY, OPK, XON, JUNO, ATML, ANAC, VGR, DPLO, KITE, FSIC, NVRO",2016-02-29 20:33:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iN-dCgMc7tU/after-hours-earnings-report-for-february-29-2016-brx-wday-opk-xon-juno-atml-anac-vgr-dplo-kite-fsic-nvro-cm586261,The following companies are expected to report earnings after hours on 02 29 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Brixmor Property Group Inc. ( BRX ) is reporting for
NVRO,NVRO:US,BBG001K61W36,"Noteworthy Thursday Option Activity: NVRO, ANET, JWN",2016-02-18 21:44:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TtBxRRpsbyU/noteworthy-thursday-option-activity-nvro-anet-jwn-cm581792,"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Nevro Corp (Symbol NVRO), where a total of 9,242 contracts have traded so far, representing approximately 924,200 underlying shares. That amounts to"
NVRO,NVRO:US,BBG001K61W36,"Commit To Buy Nevro Corp At $50, Earn 15.4% Annualized Using Options",2016-02-02 18:13:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MDippLLnIdw/commit-to-buy-nevro-corp-at-50-earn-154-annualized-using-options-cm573626,"Investors eyeing a purchase of Nevro Corp (Symbol NVRO) stock, but cautious about paying the going market price of $63.50 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in"
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the Leerink Partners 5th Annual Global Healthcare Conference,2016-01-27 21:23:33 +0000,http://www.publicnow.com/view/868C7C0A55B19DF69BD1FDE07EF5306383C7043A,"[at noodls] - , /PRNewswire/ -- (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that its management will be presenting ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue,2016-01-11 12:47:20 +0000,http://www.noodls.com/view/938D62F6786829739C273BF1EC3663C7FAF2C609,"[at noodls] - , /PRNewswire/ -- (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced its preliminary unaudited revenue ..."
NVRO,NVRO:US,BBG001K61W36,"Zosano Pharma Announces Appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer",2016-01-07 21:30:05 +0000,http://www.noodls.com/view/CC38F02502750BD9180CA733531DF3FC5DA20767,"[at noodls] - FREMONT, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage pharmaceutical company, today announced the appointment of Konstantinos Alataris, Ph.D. as President ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the J.P. Morgan 34th Annual Healthcare Conference,2015-12-28 21:18:02 +0000,http://www.noodls.com/view/F79069556AA6DCDC39F08E2F9C4682A977835851,"[at noodls] - , /PRNewswire/ -- (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that its management will be presenting ..."
NVRO,NVRO:US,BBG001K61W36,Chemours and Greatbatch are big market movers,2015-12-01 21:32:09 +0000,http://sg.finance.yahoo.com/news/chemours-greatbatch-big-market-movers-213209224.html,Chemours and Greatbatch are big market movers
NVRO,NVRO:US,BBG001K61W36,"Nevro Announces the U.S. Patent and Trademark Office's Denial of Boston Scientific Petitions for Inter Partes Review of U.S. Patent No. 8,359,102",2015-11-30 21:33:06 +0000,http://www.noodls.com/view/50B865E49A396625C0B2294F2A806FBE109E552C,"[at noodls] - Nevro Announces the U.S. Patent and Trademark Office's Denial of Boston Scientific Petitions for Inter Partes Review of U.S. Patent No. 8,359,102"
NVRO,NVRO:US,BBG001K61W36,Nevro reports 3Q loss,2015-11-09 22:03:40 +0000,http://sg.finance.yahoo.com/news/nevro-reports-3q-loss-220340727.html,Nevro reports 3Q loss
NVRO,NVRO:US,BBG001K61W36,Nevro Reports Third Quarter 2015 Financial Results,2015-11-09 21:16:20 +0000,http://www.noodls.com/view/1115A597E8323D304515205283E9AFDFF3B5FBD0,"[at noodls] - REDWOOD CITY, Calif., Nov. 9, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Report Operating Results for the Third Quarter 2015,2015-10-20 20:43:01 +0000,http://www.noodls.com/view/F3B3EE285FF02911DE50F7EEB150A3CC9C788513,"[at noodls] - REDWOOD CITY, Calif., Oct. 20, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ..."
NVRO,NVRO:US,BBG001K61W36,Zosano Pharma Announces New Executive Appointment and Management Change,2015-09-08 20:48:01 +0000,http://www.noodls.com/view/D6D414A58690C99B214992D3298109316C1F7BAE,"[at noodls] - FREMONT, Calif., Sept. 8, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch ..."
NVRO,NVRO:US,BBG001K61W36,Nevro to Present at the Morgan Stanley Global Healthcare Conference,2015-09-03 20:05:04 +0000,http://www.noodls.com/view/330B1B0928233FF0FD21E956A257B659F2FABE09,"[at noodls] - Download this Press Release (PDF 39 KB ) MENLO PARK, Calif., Sept. 3, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions ..."
NVRO,NVRO:US,BBG001K61W36,Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board,2015-09-01 20:23:07 +0000,http://www.noodls.com/view/FA09212DE35DB1C78013A397B8A45F11C9D2F162,"[at noodls] - Download this Press Release (PDF 40 KB ) For Inter Partes Review of U.S. Patent No. 8,359,102 MENLO PARK, Calif., Sept. 1, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company ..."
